BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34508140)

  • 1. Development and validation of a discrimination model between primary PLA2R-negative membranous nephropathy and minimal change disease confirmed by renal biopsy.
    Wu F; Zhang Y; Cui W; Dong Y; Geng Y; Liu C; Li Z; Xie Y; Cai X; Shang J; Xiao J; Zhao Z
    Sci Rep; 2021 Sep; 11(1):18064. PubMed ID: 34508140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characteristics and prognosis of hepatitis B associated membranous nephropathy and idiopathic membranous nephropathy complicated with hepatitis B virus infection.
    Wang R; Wu Y; Zheng B; Zhang X; An D; Guo N; Wang J; Guo Y; Tang L
    Sci Rep; 2021 Sep; 11(1):18407. PubMed ID: 34526634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cohort study of membranous nephropathy, primary or secondary.
    Arghiani M; Zamani BH; Nazemian F; Samadi S; Afsharian MS; Habibzadeh M; Eslami S; Sabbagh MG
    BMC Nephrol; 2021 Apr; 22(1):138. PubMed ID: 33874909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain.
    L'Imperio V; Pieruzzi F; Sinico RA; Nebuloni M; Granata A; Smith A; Radice A; Pagni F
    J Nephrol; 2018 Aug; 31(4):543-550. PubMed ID: 29626294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
    Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
    Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sjögren's syndrome complicated with membranous nephropathy, a cause or coincidence?
    Chen R; Wang J; Xie Q; Xue J; Hao C
    Int J Rheum Dis; 2021 Aug; 24(8):1086-1094. PubMed ID: 34223708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies.
    Bobart SA; De Vriese AS; Pawar AS; Zand L; Sethi S; Giesen C; Lieske JC; Fervenza FC
    Kidney Int; 2019 Feb; 95(2):429-438. PubMed ID: 30665573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy.
    Xie Q; Li Y; Xue J; Xiong Z; Wang L; Sun Z; Ren Y; Zhu X; Hao CM
    Am J Nephrol; 2015; 41(4-5):345-53. PubMed ID: 26087695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy.
    Svobodova B; Honsova E; Ronco P; Tesar V; Debiec H
    Nephrol Dial Transplant; 2013 Jul; 28(7):1839-44. PubMed ID: 23223223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary membranous glomerulonephritis with negative serum PLA2R in haemophilia A successfully managed with rituximab - case report and review of the literature.
    Meyer N; Cooper W; Kirwan P; Garsia R; Dunkley S; Gracey DM
    BMC Nephrol; 2021 Jul; 22(1):268. PubMed ID: 34294065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of the gut microbiota and clinical indicators as a potential index for differentiating idiopathic membranous nephropathy and minimal change disease.
    Jiang Y; Wang T; Yu W; Wu F; Guo R; Li H; Zhang Y; Yan G; Wang L; Zhao Z
    Ren Fail; 2023 Dec; 45(1):2209392. PubMed ID: 37199269
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.
    Jatem Escalante E; Segarra Medrano A; Carnicer Cáceres C; Martín-Gómez MA; Salcedo Allende MT; Ostos Roldan H; Agraz Pamplona I
    Nefrologia; 2015; 35(5):479-86. PubMed ID: 26306972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with detection of myeloperoxidase and phospholipase A
    Tominaga K; Uchida T; Imakiire T; Itoh K; Shimazaki H; Nakanishi K; Kumagai H; Oshima N
    BMC Nephrol; 2018 May; 19(1):120. PubMed ID: 29792176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy.
    Dong HR; Wang YY; Cheng XH; Wang GQ; Sun LJ; Cheng H; Chen YP
    PLoS One; 2016; 11(5):e0156263. PubMed ID: 27223897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
    Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
    BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study.
    Xie Z; Dong W; Li Z; Chen Y; Song L; Li R; Wu Y; Fu L; Liang H; Tao Y; Xie J; Wang W; Liu S; Ye Z; Shi W; Liang X
    Nephrology (Carlton); 2020 Mar; 25(3):219-229. PubMed ID: 31900967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-transplant phospholipase A2 receptor autoantibody concentration is associated with clinically significant recurrence of membranous nephropathy post-kidney transplantation.
    Gupta G; Fattah H; Ayalon R; Kidd J; Gehr T; Quintana LF; Kimball P; Sadruddin S; Massey HD; Kumar D; King AL; Beck LH
    Clin Transplant; 2016 Apr; 30(4):461-9. PubMed ID: 26854647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
    Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA
    J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic significance of C4d in membranous nephropathy].
    Dorado EG; Zambrano León E; García Fernández MV; Khoury M; Rausch S
    Medicina (B Aires); 2024; 84(3):468-473. PubMed ID: 38907960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Usefulness of Phospholipase A2 Receptor and IgG4 Detection in Differentiation Primary Membranous Nephropathy From Secondary Membranous Nephropathy in Renal Biopsy.
    Yeo MK; Kim YH; Choi DE; Choi SY; Kim KH; Suh KS
    Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):591-598. PubMed ID: 28362702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.